Bitterman Robert J — SEC insider filings
SEC reporting owner CIK 1304395. 31 insider filings on record with FilingPulse; latest filed 2026-11-10.
Transaction summary — filings shown
Covers all 31 filings on record, filed 2021-03-03 to 2026-11-10. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): 23 legs across 20 filings — 89,916 shares, $96,560 total (shares × price as filed).
- Open-market sales (code S, non-derivative): none reported.
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 12.
- Largest priced transaction: purchase of 25,000 shares @ $0.82 ($20,500) in Phio Pharmaceuticals Corp., filed 2026-11-10.
By issuer — same filings
Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Issuer | Role (as filed) | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|---|
| Phio Pharmaceuticals Corp. (PHIO) | Chairman, Pres. & CEO, Director | 31 | 23 legs · 89,916 sh · $96,560 | — | 12 |
Insider filings — Bitterman Robert J
| Filed | Form | Issuer | Reported transactions | Source |
|---|---|---|---|---|
| 2026-11-10 | 4 | Phio Pharmaceuticals Corp. (PHIO) | Purchase (P): 25,000 @ $0.82 | EDGAR |
| 2026-09-29 | 4 | Phio Pharmaceuticals Corp. (PHIO) | Grant/award (A): 400,000 @ $0 | EDGAR |
| 2026-09-23 | 4 | Phio Pharmaceuticals Corp. (PHIO) | Purchase (P): 2,000 @ $1.03 | EDGAR |
| 2026-09-15 | 4 | Phio Pharmaceuticals Corp. (PHIO) | Tax withholding (F): 68,550 @ $1.03 | EDGAR |
| 2026-08-19 | 4 | Phio Pharmaceuticals Corp. (PHIO) | Purchase (P): 10,000 @ $1.06 | EDGAR |
| 2026-06-29 | 4 | Phio Pharmaceuticals Corp. (PHIO) | Purchase (P): 10,000 @ $0.99 | EDGAR |
| 2026-02-06 | 4 | Phio Pharmaceuticals Corp. (PHIO) | Grant/award (A): 120,000 @ $0 | EDGAR |
| 2026-01-02 | 4 | Phio Pharmaceuticals Corp. (PHIO) | Purchase (P): 5,000 @ $1.03 | EDGAR |
| 2025-12-29 | 4 | Phio Pharmaceuticals Corp. (PHIO) | Purchase (P): 5,000 @ $1.02 | EDGAR |
| 2025-11-24 | 4 | Phio Pharmaceuticals Corp. (PHIO) | Purchase (P): 5,000 @ $1.14 | EDGAR |
| 2025-11-19 | 4 | Phio Pharmaceuticals Corp. (PHIO) | Purchase (P): 5,000 @ $1.27 | EDGAR |
| 2025-09-15 | 4 | Phio Pharmaceuticals Corp. (PHIO) | Tax withholding (F): 4,111 @ $2.32 · Grant/award (A): 250,000 @ $0 | EDGAR |
| 2025-06-11 | 4 | Phio Pharmaceuticals Corp. (PHIO) | Purchase (P): 2,000 @ $2.42 | EDGAR |
| 2025-06-10 | 4 | Phio Pharmaceuticals Corp. (PHIO) | Purchase (P): 1,500 @ $2.75 | EDGAR |
| 2025-05-23 | 4 | Phio Pharmaceuticals Corp. (PHIO) | Purchase (P): 3,000 @ $1.77 · Purchase (P): 1,200 @ $1.78 | EDGAR |
| 2024-09-13 | 4 | Phio Pharmaceuticals Corp. (PHIO) | Grant/award (A): 15,500 @ $0 | EDGAR |
| 2024-06-11 | 4 | Phio Pharmaceuticals Corp. (PHIO) | Purchase (P): 1,000 @ $0.74 | EDGAR |
| 2024-06-10 | 4 | Phio Pharmaceuticals Corp. (PHIO) | Purchase (P): 1,000 @ $0.75 | EDGAR |
| 2024-02-27 | 4 | Phio Pharmaceuticals Corp. (PHIO) | Purchase (P): 2,500 @ $0.91 | EDGAR |
| 2024-02-22 | 4 | Phio Pharmaceuticals Corp. (PHIO) | Tax withholding (F): 1,804 @ $0.76 | EDGAR |
| 2023-10-03 | 4 | Phio Pharmaceuticals Corp. (PHIO) | Tax withholding (F): 917 @ $1.51 | EDGAR |
| 2023-07-05 | 4 | Phio Pharmaceuticals Corp. (PHIO) | Purchase (P): 1,000 @ $2.88 · Purchase (P): 1,000 @ $2.84 | EDGAR |
| 2023-02-22 | 4 | Phio Pharmaceuticals Corp. (PHIO) | Grant/award (A): 11,000 @ $0 | EDGAR |
| 2022-12-15 | 4 | Phio Pharmaceuticals Corp. (PHIO) | Purchase (P): 2,000 @ $0.39 | EDGAR |
| 2022-12-08 | 4 | Phio Pharmaceuticals Corp. (PHIO) | Purchase (P): 2,000 @ $0.39 | EDGAR |
| 2022-12-06 | 4 | Phio Pharmaceuticals Corp. (PHIO) | Purchase (P): 2,000 @ $0.43 | EDGAR |
| 2022-11-29 | 4 | Phio Pharmaceuticals Corp. (PHIO) | Purchase (P): 2,500 @ $0.42 · Purchase (P): 215 @ $0.40 | EDGAR |
| 2022-11-16 | 4 | Phio Pharmaceuticals Corp. (PHIO) | Purchase (P): 1 @ $1,750 | EDGAR |
| 2022-10-03 | 4 | Phio Pharmaceuticals Corp. (PHIO) | Grant/award (A): 40,000 @ $0 | EDGAR |
| 2022-02-16 | 4 | Phio Pharmaceuticals Corp. (PHIO) | Grant/award (A): 10,000 @ $0 | EDGAR |
| 2021-03-03 | 4 | Phio Pharmaceuticals Corp. (PHIO) | Grant/award (A): 10,000 @ $0 | EDGAR |
FilingPulse's Form 4 archive currently extends back to 2021-01-29 and is expanding backward through EDGAR history; Forms 3 and 5 are covered live-forward since 2026-09-23 (no 3/5 history). Earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.
GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1304395 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. Get a free API key → · API docs